logo
Select company
Select metric
$ -26.55MConsolidated Income
VS
Market
26
Sector
50
Industry
63
History
17
$ 0.47Close
$ 0.27 - $ 3.09 52-Week Range
Ticker Information

Ticker

MBRX

Company Name

MOLECULIN BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MOLECULIN BIOTECH INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MBRX - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -26.55M
3/31/2025$ -23.23M
12/31/2024$ -21.76M
9/30/2024$ -30.15M
6/30/2024$ -25.17M
3/31/2024$ -26.82M
12/31/2023$ -29.77M
9/30/2023$ -26.27M
6/30/2023$ -29.27M
3/31/2023$ -30.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MOLECULIN BIOTECH INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -18.51M.
  • Over the past 5 years, MOLECULIN BIOTECH INC's average Cons. Inc. has been $ -23.26M.
  • The median Cons. Inc. for MOLECULIN BIOTECH INC during this period was $ -24.15M
  • MOLECULIN BIOTECH INC reached its highest Cons. Inc. over the past 5 years at $ -14.72M.
  • The lowest Cons. Inc. recorded by MOLECULIN BIOTECH INC in the same timeframe $ -30.15M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

MBRX - Consolidated Income, Last 5 years

$ -30.15M

Minimum

Sep 30, 2024

$ -14.72M

Maximum

Jun 30, 2021

$ -23.26M

Average

$ -24.15M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M